Inactive Instrument

Qiagen Stock price Nasdaq

Equities

NL0012169213

Biotechnology & Medical Research

Sales 2024 * 2.01B Sales 2025 * 2.16B Capitalization 9.77B
Net income 2024 * 397M Net income 2025 * 446M EV / Sales 2024 * 5 x
Net Debt 2024 * 303M Net cash position 2025 * 281M EV / Sales 2025 * 4.4 x
P/E ratio 2024 *
24.9 x
P/E ratio 2025 *
21.9 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.49%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 60 15-01-31
Founder 69 96-04-28
Director of Finance/CFO 56 98-12-31
Members of the board TitleAgeSince
Director/Board Member 75 11-05-31
Founder 69 96-04-28
Chairman 66 13-06-25
More insiders
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2022, the group developed more than 500 core consumable products and automated solutions through its over 35 locations worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (34.2%), the United States (42.5%), America (4.1%) and other (19.2%).
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Qiagen N.V.
  4. Stock Qiagen - Nasdaq